- Home
- VCEL vs CLOV Comparison
VCEL vs CLOV Comparison
Compare VCEL & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- CLOV
- Stock Information
- Founded
- VCEL 1989
- CLOV 2014
- Country
- VCEL United States
- CLOV United States
- Employees
- VCEL N/A
- CLOV N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- CLOV Medical Specialities
- Sector
- VCEL Health Care
- CLOV Health Care
- Exchange
- VCEL Nasdaq
- CLOV Nasdaq
- Market Cap
- VCEL 2.1B
- CLOV 1.7B
- IPO Year
- VCEL 1997
- CLOV N/A
- Fundamental
- Price
- VCEL $41.49
- CLOV $3.41
- Analyst Decision
- VCEL Strong Buy
- CLOV Strong Buy
- Analyst Count
- VCEL 8
- CLOV 3
- Target Price
- VCEL $61.75
- CLOV $4.83
- AVG Volume (30 Days)
- VCEL 547.9K
- CLOV 5.6M
- Earning Date
- VCEL 05-08-2025
- CLOV 05-06-2025
- Dividend Yield
- VCEL N/A
- CLOV N/A
- EPS Growth
- VCEL 521.85
- CLOV N/A
- EPS
- VCEL 0.05
- CLOV N/A
- Revenue
- VCEL $238,541,000.00
- CLOV $1,486,540,000.00
- Revenue This Year
- VCEL $23.23
- CLOV $45.11
- Revenue Next Year
- VCEL $24.41
- CLOV $16.04
- P/E Ratio
- VCEL $698.68
- CLOV N/A
- Revenue Growth
- VCEL 14.80
- CLOV N/A
- 52 Week Low
- VCEL $37.39
- CLOV $0.79
- 52 Week High
- VCEL $63.00
- CLOV $4.87
- Technical
- Relative Strength Index (RSI)
- VCEL 49.55
- CLOV 46.17
- Support Level
- VCEL $37.48
- CLOV $3.26
- Resistance Level
- VCEL $44.41
- CLOV $3.90
- Average True Range (ATR)
- VCEL 1.86
- CLOV 0.18
- MACD
- VCEL 0.61
- CLOV 0.00
- Stochastic Oscillator
- VCEL 58.40
- CLOV 32.88
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.